* 由恒瑞医药600276.SS董事长孙飘扬之妻女控股的中国翰森制药3692.HK周一早盘涨幅扩大至5%，报21.1港元。
* 野村在报告中表示，将翰森制药目标价由18.36港元上调至19.86港元，该公司去年净利润同比增长33.4%至43.7亿元人民币，较野村的预估高8.6%，因其抗肿瘤药物阿美乐销售表现更强劲、毛利率提升、销售开支降低。
* 翰森制药今年迄今劲涨21.5%，同期恒生指数.HSI大幅上扬18.1%。
* 恒生综合行业指数 - 医疗保健业.HSCIH盘中一度升0.8%。（完）
更多股市简讯请点选CN-CMN-HOT
(发稿 徐凯文；审校 吴云凌)
((kaiwen.xu@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.